Svai S. Sanford
CIK: 0001591411
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
RANI
Rani Therapeutics Holdings, Inc.
Officer
Discretionary Trading P&L
Holdings
About Sanford Svai S
Sanford Svai S (SEC CIK 0001591411) files insider reports with the SEC as Chief Financial Officer of Rani Therapeutics Holdings, Inc. (RANI).
Signal8 holds 1 ownership filing by Sanford Svai S, a Form 4, filed on May 23, 2025. Those filings report 1 transaction, the latest on May 23, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Sanford Svai S's filings is in SAN JOSE, CA.
Recent filings by Sanford Svai S
- May 23, 2025: Grant or award of RANI derivative securities (Form 4, code A).
Other insiders filing for Rani Therapeutics Holdings, Inc. (RANI)
- Imran Talat, Chief Executive Officer
- Javadi Alireza, Chief Technical Officer
- Gilson Michelle, Director
- IMRAN MIR A, Director
- Maestas Nicholas, Chief Financial Officer
- McKinley Kate, Chief Business Officer